AI and Healthcare

Healthcare is drowning in inefficiency - 80% of data is noise, and clinicians waste precious time on tasks that don’t improve patient outcomes. But AI is flipping the script. Imagine diagnosing lung cancer in seconds instead of digging through hours of records, or boosting revenue (RVUs) while actually enhancing care quality. Uncover the real barriers to AI adoption and how new platforms are cutti...

Millions of dollars are being wasted in healthcare every year—not because of a lack of resources, but because people aren’t accessing the help that already exists. AI is starting to change that. By streamlining access to underused benefit programs, AI can help patients avoid unnecessary ER visits, reduce hospital strain, and cut costs across the healthcare system. Dr. Alister Martin shares how his...

Healthcare costs are rising, but AI could be the key to fixing the system. Beyond improving patient care, AI has the potential to reduce administrative burdens, streamline workflows, and lower overall costs. Dr. Alister Martin has spent years at the intersection of medicine and social change, exploring how technology can make healthcare more efficient and accessible. This conversation looks at how...

AI adoption in healthcare comes with complexities, from regulatory hurdles to the challenge of building secure, scalable systems that align with hospital needs. Finding the right balance between innovation and data privacy is key to ensuring these technologies can be effectively integrated into medical environments.

AI is transforming healthcare by streamlining medical workflows, enhancing drug development, and driving more efficient, data-driven solutions. Krish Ramadurai shares insights on AI-native health tech, digital pathology, and the challenges of scaling automation in biotech, highlighting the impact of technology on the future of medicine.

Picking the right drugs is a high-stakes game. Get it right more often than the competition, and the rewards are massive. Miss a few, and you’re out. So how do top investors and biotech leaders make smart bets? Understanding what pharma actually wants, securing multiple key advocates, and strategically managing risk are all part of the playbook. From clinical-stage assets to investor-backed decisi...

AI in healthcare is evolving fast, but how much of it is real progress—and how much is just hype? While AI-driven tools are reshaping clinical workflows and decision-making, many solutions struggle with integration, regulatory hurdles, and real-world adoption. The real winners? Companies that master proprietary data, streamline physician workflows, and build AI solutions that actually work within...

The future of healthcare is evolving rapidly, and technology is playing a bigger role than ever. Pelu Tran shares insights on how AI, data-driven decision-making, and digital tools are reshaping patient care and the way doctors work. From improving clinical workflows to making healthcare more accessible, these innovations are changing the industry in real time. We also explore the challenges of in...

AI is transforming biotech, making drug development more predictable. From improving drug discovery to tackling the translatability crisis, new advancements are optimizing clinical success rates. Learn why many AI-designed drugs fail, how human data is reshaping the field, and why repurposing shelved assets might be the next big opportunity in pharma.

Waiting until cancer is already formed before acting? That approach needs to change. Science now has the tools to detect the earliest warning signs—long before a tumor even develops. Breakthrough technologies like AI-driven monitoring and implantable sensors could transform how we detect disease, tracking subtle biological changes in real time. Instead of periodic tests that might miss critical mo...

Understanding lab results can be overwhelming, but what if AI could help make sense of the data and improve patient care? Dr. Sanjay Juneja and David Norris explore how artificial intelligence is reshaping healthcare—reducing administrative burdens, detecting conditions like iron deficiency, and streamlining workflows. They also discuss how AI is giving doctors more time with patients by handling...

Cancer detection is long overdue for a revolution. Current screening methods miss too much, cost billions, and often lead to false positives. But what if we could catch cancer at the very first cell—before it ever becomes a threat? A breakthrough technology could make that possible. AI, continuous monitoring, and implantable devices are reshaping how we detect disease, moving beyond outdated metho...

Early cancer detection can save lives, yet traditional treatments often focus on late-stage disease. This episode explores the critical need for a shift in approach—studying human cells directly, improving model systems, and building a comprehensive tissue repository to better understand cancer at its earliest stages. Dr. Azra Raza shares insights on key differences in cancer progression between c...

Mika Newton and Dr. Nigam Shah explore whether healthcare technology and AI are addressing the right problems. They discuss the tendency to focus on easy solutions like using language models to respond to patient messages, which may not save time as expected. The conversation highlights the need to redefine goals and use AI for innovative approaches rather than just replicating existing tasks done...

Mika Newton speaks with Dr. Nigam Shah, a Stanford professor and Chief Data Scientist at Stanford Healthcare, about AI’s role in healthcare. They discuss evaluating AI’s impact on patient care, the challenges of benchmarking AI models, and the importance of using real-world data. The conversation explores how AI can enhance clinical decision-making, the need for well-defined research questions, an...

AI is reshaping healthcare, from clinical workflows to drug discovery and the rise of full-stack biotech companies. But what are the real challenges, and where is AI falling short? Mika Newton sits down with Krish Ramadurai from AIX Ventures to break down the complexities of AI in healthcare, the importance of domain expertise, and the push to automate clinical development. They also discuss how s...

Join Dr. Sanjay Juneja and Columbia University professor Dr. Azra Raza in an in-depth discussion about the transformative potential of AI and technology in early cancer detection. Dr. Raza shares her insights on how continuous monitoring and innovative technologies could find cancer at the 'first cell stage,' long before traditional methods. Learn about her journey from pediatric oncology to estab...

This episode features Nigam Shah discussing the sustainability of AI in healthcare, focusing on challenges in development, validation, and regulation. The conversation explores the limitations of current AI models, the evolving role of governance, and the need for localized validation to ensure accuracy and relevance.

In this episode, Mika Newton speaks with Dr. Nigam Shah, a professor at Stanford and Chief Data Scientist at Stanford Healthcare, about the challenges and opportunities of AI in healthcare. They discuss the sustainability of AI development, the complexities of regulation, and the importance of localized validation. The conversation explores how AI can enhance clinical decision-making, optimize hea...

This podcast episode explores the intersection of AI and healthcare, focusing on drug development, repurposing, and access to medical treatments. Mika Newton speaks with Bob Battista about the challenges of sharing pharmaceutical data, regulatory barriers, and how AI could enhance clinical decision-making. They discuss real-world data, patient knowledge, and the role of technology in optimizing tr...

Mika Newton and Bob Battista explore how AI could reshape healthcare by giving patients greater control over their medical decisions. They discuss the potential for AI to process vast amounts of clinical data, improve access to relevant treatments, and bridge gaps in health literacy. The conversation also raises important questions about data sharing, patient autonomy, and the future of AI-driven...

Mika Newton and Bob Battista discuss how AI is shaping healthcare decision-making. They explore its role in analyzing clinical evidence, updating guidelines dynamically, and personalizing treatment recommendations. The conversation also highlights challenges like regulatory restrictions and data silos that limit AI’s full potential in the industry.

Drug repurposing offers a way to find new treatments using existing medications, but regulatory hurdles and financial disincentives often prevent progress. Mika Newton and Bob Battista examine the challenges of data sharing in the pharmaceutical industry, the high costs of clinical trials, and why companies hesitate to pursue niche indications. They also explore potential policy solutions that cou...

Mika Newton and Tom Neyarapally discuss how AI is changing the landscape of drug discovery. They examine the role of machine learning, patient data, and computational tools in accelerating the process, reducing costs, and improving the chances of developing effective treatments. The conversation covers how AI-driven screening, drug repurposing, and real-world data integration are helping to overco...

Mika Newton and Tom Neyarapally explore how advancements in AI are accelerating the development of new algorithms, improving target discovery, and enhancing high-throughput screening. The conversation highlights the challenges and opportunities in aggregating innovative technologies, the convergence of AI tools in healthcare, and the potential for personalized and economically viable drug developm...